Exact Mass: 306.1216
Exact Mass Matches: 306.1216
Found 125 metabolites which its exact mass value is equals to given mass value 306.1216
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Z-Gly-Pro
KEIO_ID Z003; [MS3] KO009084 KEIO_ID Z003; [MS2] KO009083 KEIO_ID Z003
(1aalpha,2beta,3alpha,11calpha)-1a,2,3,11c-Tetrahydro-6,11-dimethylbenzo[6,7]phenanthro[3,4-b]oxirene-2,3-diol
(1aalpha,2beta,3alpha,11calpha)-1a,2,3,11c-Tetrahydro-6,11-dimethylbenzo[6,7]phenanthro[3,4-b]oxirene-2,3-diol is considered to be practically insoluble (in water) and relatively neutral
Metioprim
C254 - Anti-Infective Agent > C258 - Antibiotic
7-(3-Methylbut-2-enyloxy)flavone|7-(3-methyl-but-2-enyloxy)-2-phenyl-chromen-4-one|7-gamma,gamma-dimethylallyloxyflavanone|Cordoin-flavon
plectranthon A|Plectranthon A ( = 3-Hydroxy-5,7,8-trimethyl-2-(prop-2-enyl)phenanthren-1,4-dion)|Plectranthone A
2,3-Dihydro-3,9-dihydroxy-4-phenyl-5-methoxy-1H-phenalene
plectranthon D|Pseudoplectranthon D ( = 3-Hydroxy-7,8,10-trimethyl-2-(prop-2-enyl)phenanthren-1,4-dion)
(E)-1-(5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)-3-phenylprop-2-en-1-one|1-(5-Hydroxy-2,2-dimethyl-2H-chromen-6-yl)-3t-phenyl-propenon|1-(5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)-3t-phenyl-propenone|Lonchocarpin|lonchocarpine
nigerapyrone A
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by a methoxy group at position 4 and a 4,6-dimethylbiphenyl-2-yl group at position 6. It has been isolated from an endophytic fungus, Aspergillus niger.
3-hydroxy-1-keto-3-methyl-8-methoxy-1,2,3, 4-tetrahydro-benz[alpha]anthracene
(1R)-2,3-dihydro-4,9-dihydroxy-8-methoxy-1-phenylphenalene|2,3-dihydro-4,9-dihydroxy-8-methoxy-1-phenylphenalene
(E)-1-(5-hydroxy-2,2-dimethylchromen-6-yl)-3-phenylprop-2-en-1-one
Gly Gly Ser Ser
Gly Ser Gly Ser
Gly Ser Ser Gly
Ser Gly Gly Ser
Ser Gly Ser Gly
Ser Ser Gly Gly
3-AMINO-8-BENZYL-8-AZABICYCLO[3.2.1]OCTANE DIHYDROCHLORIDE MONOHYDRATE (3-ENDO)-
Potassium (4-tert-butoxycarbonylpiperazin-1-yl)methyltrifluoroborate
1-[2-(4-methoxyphenyl)ethyl]piperidin-4-amine,dihydrochloride
7-Hydroxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one
3-methoxy-6-methyl-1-(3,4,5-trimethoxyphenyl)pyridazin-4-one
Ethyl 4-hydroxy-1-(2-methoxyethyl)-7-methyl-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate
4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid
N-(3-PHENYL-4,5,6,7-TETRAHYDROBENZO[D]THIAZOL-2(3H)-YLIDENE)ANILINE
5-(N-TERT-BUTOXYCARBONYLAMINOMETHYL)-4-PHENYL-1,2,4-TRIAZOLE-3-THIOL
(2R,5S)-5-Benzyl-3-methyl-2-(5-methylfuran-2-yl)imidazolidin-4-one Hydrochloride
4H-1,4-BENZODIAZEPINE-4,8-DICARBOXYLIC ACID-1,2,3,5-TETRAHYDRO-2-OXO-4-(1,1-DIMETHYLETHYL) ESTER
1-(5-Tert-butyl-2-methyl-2H-pyrazol-3-YL)-3-(4-chloro-phenyl)-urea
N-cyano-N-propan-2-ylcarbamimidothioic acid [2-(2-methoxyanilino)-2-oxoethyl] ester
4-(4-nitrophenyl)-N-prop-2-enyl-1-piperazinecarbothioamide
N-[4-[2-(2-methoxyethylamino)-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide
1-(2,3-Dihydroindol-1-yl)-2-(5-pyridin-4-yl-2-tetrazolyl)ethanone
2-(1,3-benzodioxol-5-yl)-N-(3-pyridinylmethyl)-4-pyrimidinamine
2,3-Dihydroindol-1-yl-(6-fluoro-2-methyl-4-quinolinyl)methanone
2-(2-furanyl)-5-methyl-6-(phenylmethyl)-1H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one
3-(4-Fluorophenyl)-5-(2-furanyl)-2-phenyl-3,4-dihydropyrazole
(3S)-4-oxo-3-phenyl-3-propan-2-yldiazetidine-1,2-dicarboxylic acid dimethyl ester
8-(3-Phenylpropenoyl)-2,2-dimethyl-2H-1-benzopyran-7-ol
(2S,3R,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3S,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3S,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)azetidine-2-carbonitrile
(2R,3R,4S)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
2-[(2R,3R,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
(2R,3S,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
2-[(2S,3R,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2R,3S,6R)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2S,3S,6R)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2S,3S,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
2-[(2R,3R,6R)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid
(2S,3R,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3R,4R)-3-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(1aalpha,2beta,3alpha,11calpha)-1a,2,3,11c-Tetrahydro-6,11-dimethylbenzo[6,7]phenanthro[3,4-b]oxirene-2,3-diol
Facinicline (hydrochloride)
Facinicline hydrochloride (RG3487 hydrochloride) is an orally active nicotinic α7 receptor partial agonist, with a Ki of 6 nM for α7 human nAChR. Facinicline hydrochloride (RG3487 hydrochloride) improves cognition and sensorimotor gating in rodents. Facinicline hydrochloride (RG3487 hydrochloride) shows high affinity (antagonist) to 5-HT3Rs with a Ki value of 1.2 nM[1].
ML353
ML353 is a selective ligand of mGlu5 silent allosteric modulator (SAM) with an Ki value of 18.2 nM. ML353 improves the affinity of common allosteric sites, 20-fold higher than the previous mGlu5 SAM tool compound 5mpep. ML353 has potential applications in solving the intrinsic activity of SAM in vivo or as a agent blocker[1]. ML353 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.